GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Gross Margin %

Aarti Drugs (BOM:524348) Gross Margin % : 35.95% (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Aarti Drugs's Gross Profit for the three months ended in Mar. 2024 was ₹2,229 Mil. Aarti Drugs's Revenue for the three months ended in Mar. 2024 was ₹6,200 Mil. Therefore, Aarti Drugs's Gross Margin % for the quarter that ended in Mar. 2024 was 35.95%.


The historical rank and industry rank for Aarti Drugs's Gross Margin % or its related term are showing as below:

BOM:524348' s Gross Margin % Range Over the Past 10 Years
Min: 20.1   Med: 23.11   Max: 33.65
Current: 33.65


During the past 13 years, the highest Gross Margin % of Aarti Drugs was 33.65%. The lowest was 20.10%. And the median was 23.11%.

BOM:524348's Gross Margin % is ranked worse than
71.73% of 987 companies
in the Drug Manufacturers industry
Industry Median: 46.24 vs BOM:524348: 33.65

Aarti Drugs had a gross margin of 35.95% for the quarter that ended in Mar. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Aarti Drugs was 9.50% per year.


Aarti Drugs Gross Margin % Historical Data

The historical data trend for Aarti Drugs's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Gross Margin % Chart

Aarti Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.38 27.86 20.24 30.47 33.65

Aarti Drugs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.56 32.48 33.12 33.12 35.95

Competitive Comparison of Aarti Drugs's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Drugs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Drugs's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Drugs's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Aarti Drugs's Gross Margin % falls into.



Aarti Drugs Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Aarti Drugs's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=8508.6 / 25285.8
=(Revenue - Cost of Goods Sold) / Revenue
=(25285.8 - 16777.2) / 25285.8
=33.65 %

Aarti Drugs's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=2228.8 / 6199.9
=(Revenue - Cost of Goods Sold) / Revenue
=(6199.9 - 3971.1) / 6199.9
=35.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Aarti Drugs  (BOM:524348) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Aarti Drugs had a gross margin of 35.95% for the quarter that ended in Mar. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Aarti Drugs Gross Margin % Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Drugs (BOM:524348) Business Description

Traded in Other Exchanges
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400 022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.

Aarti Drugs (BOM:524348) Headlines

No Headlines